Thymidine phosphorylase in cancer aggressiveness and chemoresistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thymidine phosphorylase in cancer aggressiveness and chemoresistance

Published:2018-06 Issue: Volume:132 Page:15-20
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Furukawa Tatsuhiko,Tabata Sho,Yamamoto Masatatsu,Kawahara Kohichi,Shinsato Yoshinari,Minami Kentaro,Shimokawa Michiko,Akiyama Shin-ichi

Funder

JSPS KAKENHI

Shinnihon Foundation of Advanced Medical Treatment Research

Kodama Memorial Fund

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression;Akiyama;Cancer Sci.,2004

2. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment;Toi;Lancet Oncol.,2005

3. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy;Liekens;Biochem. Pharmacol.,2007

4. The dual role of thymidine phosphorylase in cancer development and chemotherapy;Bronckaers;Med. Res. Rev.,2009

5. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor;Ishikawa;Nature,1989

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary X-ray Diffraction Analysis of Purine Nucleoside Phosphorylase from the Haloalkaliphilic Bacterium Halomonas chromatireducens;Crystallography Reports;2023-12

2. D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC;Medicine;2023-11-10

3. Preliminary X-ray Diffraction Analysis of Purine Nucleoside Phosphorylase from the Haloalkaliphilic Bacterium Halomonas chromatireducens;Кристаллография;2023-11-01

4. Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil;Journal of Personalized Medicine;2023-05-31

5. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer;Frontiers in Oncology;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3